A Late Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes
NCT01890941 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2015-10-19
Summary
The purpose of this study is to evaluate the efficacy and safety of KCT-0809 compared to placebo in patients with dry eye syndromes.
Conditions
- Dry Eye Syndromes
Interventions
- DRUG
-
KCT-0809 ophthalmic solution
- DRUG
Sponsors & Collaborators
-
Kissei Pharmaceutical Co., Ltd.
lead INDUSTRY
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Primary Completion
- 2014-03-31
Countries
- Japan
More Related Trials
-
Late Phase II Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01189032 ·Status: COMPLETED ·Phase: PHASE2
-
An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
NCT02503176 ·Status: TERMINATED ·Phase: PHASE3
-
Phase 2 Study of KLS-0611 in Patients With Dry Eye Syndromes
NCT00721656 ·Status: COMPLETED ·Phase: PHASE2
-
Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01101984 ·Status: COMPLETED ·Phase: NA
-
A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease
NCT04084483 ·Status: COMPLETED ·Phase: PHASE2
-
Study of OT202 in Treating Moderate to Severe Dry Eye
NCT06435182 ·Status: COMPLETED ·Phase: PHASE2
-
Assessing Safety and Efficacy of DE-089 Ophthalmic Solution in Patients With Dry Eye Disease
NCT03216096 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Evaluating the Efficacy and Safety on Moderate to Severe Dry Eye
NCT04092907 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of TOP1630 for Dry Eye Syndrome
NCT03088605 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 1/2, RU-101 Ophthalmic Solution in Patients With Severe Dry Eye
NCT01843894 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome
NCT01670357 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome (DES)
NCT02121301 ·Status: COMPLETED ·Phase: PHASE2
-
MSCohi-O Lenses for Ocular Involvement in Sjögren's Syndrome
NCT07185139 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
NCT01468168 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
NCT01239069 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease
NCT04139122 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT00404131 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of GLH8NDE After Single and Mutiple Ocular Administrations in Healthy Korean and Caucasian Volunteers
NCT04104997 ·Status: COMPLETED ·Phase: PHASE1
-
Study of TOP1630 for Dry Eye Syndrome
NCT03833388 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye
NCT01558999 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2 Study to Evaluation the Safety and Efficacy of Orally Administered KL7016 in Patients With Dry Eye Syndrome
NCT02092207 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Evaluating HBM9036 Efficacy and Safety on Moderate to Severe Dry Eye
NCT04633213 ·Status: COMPLETED ·Phase: PHASE3
-
The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease
NCT05759208 ·Status: COMPLETED ·Phase: PHASE2
-
Study of ST-100 as Treatment for Dry Eye Disease
NCT05241470 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease
NCT03636061 ·Status: COMPLETED ·Phase: PHASE2